314 related articles for article (PubMed ID: 26139638)
21. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis.
Marik PE; Vasu T; Hirani A; Pachinburavan M
Crit Care Med; 2010 Nov; 38(11):2222-8. PubMed ID: 20711074
[TBL] [Abstract][Full Text] [Related]
22. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
[TBL] [Abstract][Full Text] [Related]
23. Stress ulcer prophylaxis versus placebo or no prophylaxis in critically ill patients. A systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
Krag M; Perner A; Wetterslev J; Wise MP; Hylander Møller M
Intensive Care Med; 2014 Jan; 40(1):11-22. PubMed ID: 24141808
[TBL] [Abstract][Full Text] [Related]
24. Effects of pharmacy resident led education on resident physician prescribing habits associated with stress ulcer prophylaxis in non-intensive care unit patients.
Agee C; Coulter L; Hudson J
Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S48-52. PubMed ID: 25991596
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
MacLaren R; Campbell J
Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
[TBL] [Abstract][Full Text] [Related]
26. Risks and Benefits of Stress Ulcer Prophylaxis for Patients With Severe Sepsis.
Sasabuchi Y; Matsui H; Lefor AK; Fushimi K; Yasunaga H
Crit Care Med; 2016 Jul; 44(7):e464-9. PubMed ID: 27002276
[TBL] [Abstract][Full Text] [Related]
27. Stress Ulcer Prophylaxis in Cardiac Surgery: A Retrospective Cohort Study to Analyze the Effects of SUP Cessation.
Mekhail A; Young P; Mekhail AM; Tinawi G; Haran C; Clayton N; Galvin S
J Intensive Care Med; 2023 Oct; 38(10):917-921. PubMed ID: 37093762
[TBL] [Abstract][Full Text] [Related]
28. Effects of stress ulcer prophylaxis in adult ICU patients receiving renal replacement therapy (Sup-Icu RENal, SIREN): Study protocol for a pre-planned observational study.
Schefold JC; Perner A; Lange T; Wetterslev J; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Marker S; Krag M; Møller MH;
Trials; 2018 Jan; 19(1):26. PubMed ID: 29321041
[TBL] [Abstract][Full Text] [Related]
29. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
Avendaño-Reyes JM; Jaramillo-Ramírez H
Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
[TBL] [Abstract][Full Text] [Related]
30. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
31. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
Marker S; Perner A; Wetterslev J; Barbateskovic M; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
Syst Rev; 2017 Jun; 6(1):118. PubMed ID: 28646925
[TBL] [Abstract][Full Text] [Related]
32. Stress ulcer prophylaxis for non-critically ill patients on a teaching service.
Hwang KO; Kolarov S; Cheng L; Griffith RA
J Eval Clin Pract; 2007 Oct; 13(5):716-21. PubMed ID: 17824863
[TBL] [Abstract][Full Text] [Related]
33. Why do physicians prescribe stress ulcer prophylaxis to general medicine patients?
Hussain S; Stefan M; Visintainer P; Rothberg M
South Med J; 2010 Nov; 103(11):1103-10. PubMed ID: 21042168
[TBL] [Abstract][Full Text] [Related]
34. Stress ulcer prophylaxis in children with status asthmaticus receiving systemic corticosteroids: a descriptive study assessing frequency of clinically important bleeding.
Sochet AA; Son S; Ryan KS; Roddy M; Barrie E; Wilsey M; McKinley SD; Nakagawa TA
J Asthma; 2020 Aug; 57(8):858-865. PubMed ID: 31046509
[No Abstract] [Full Text] [Related]
35. Appropriateness of Acid-suppressing Agents for Stress Ulcer Prophylaxis in Non-intensive Care Unit Setting in Saudi Arabia.
Malhis A; Alghamdi T; Alfandi R; Issa ZA; Alanazi H; Alfintoukh H; Baqar JB; Ali S
J Pharm Bioallied Sci; 2019; 11(1):96-101. PubMed ID: 30906145
[TBL] [Abstract][Full Text] [Related]
36. Stress Ulcer Prophylaxis in Critically Ill Children: A Multicenter Observational Study.
Duffett M; Chan A; Closs J; McGloin R; McKelvie G; Pong S; Seto W; Slaney H; Vaninetti G; Vanniyasingam T
Pediatr Crit Care Med; 2020 Feb; 21(2):e107-e113. PubMed ID: 31821206
[TBL] [Abstract][Full Text] [Related]
37. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
Krag M; Perner A; Wetterslev J; Møller MH
Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
[TBL] [Abstract][Full Text] [Related]
38. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
Boyd C; Hassig T; MacLaren R
Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
[TBL] [Abstract][Full Text] [Related]
39. Appropriateness of Acid Suppression Therapy.
De Rijdt T; Spriet I; Willems L; Blanckaert M; Hiele M; Wilmer A; Simoens S
Ann Pharmacother; 2017 Feb; 51(2):125-134. PubMed ID: 27650819
[TBL] [Abstract][Full Text] [Related]
40. Reassessing the Use of Proton Pump Inhibitors and Histamine-2 Antagonists in Critically Ill Children: A Systematic Review and Meta-Analysis.
Yao DWJ; Ong C; Eales NM; Sultana R; Wong JJ; Lee JH
J Pediatr; 2021 Jan; 228():164-176.e7. PubMed ID: 32916144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
